European Organisation for Research and Treatment of Cancer
@eortc.org
We define better treatments for all cancer patients to prolong survival and improve quality of life.
Pinned
📅 Get ready to make the most of EORTC’s upcoming events!
Mark your calendars 👇
#CancerResearch #ClinicalTrials #Oncology #EORTCevents #PatientDays #EBCC15 #Stats2026 #MCCRworkshop #ENASymp26
Mark your calendars 👇
#CancerResearch #ClinicalTrials #Oncology #EORTCevents #PatientDays #EBCC15 #Stats2026 #MCCRworkshop #ENASymp26
Cancer clinical trials turn discoveries into better treatments. EORTC leads international trials, studying not just if treatments work, but how they improve patients’ quality of life.
👉 Like & reshare to raise awareness. #WorldCancerDay #ClinicalTrials #EORTCimpact
👉 Like & reshare to raise awareness. #WorldCancerDay #ClinicalTrials #EORTCimpact
January 23, 2026 at 12:01 PM
Cancer clinical trials turn discoveries into better treatments. EORTC leads international trials, studying not just if treatments work, but how they improve patients’ quality of life.
👉 Like & reshare to raise awareness. #WorldCancerDay #ClinicalTrials #EORTCimpact
👉 Like & reshare to raise awareness. #WorldCancerDay #ClinicalTrials #EORTCimpact
🎓Tomorrow is International Day of Education, a moment to celebrate the EORTC Early Career Investigator (ECI) programme, which empowers young doctors to drive #CancerResearch forward.
Meet Ioannis, Jens & Antonella from our ECI community.
Join us: https://www.eortc.org/early-career/
Meet Ioannis, Jens & Antonella from our ECI community.
Join us: https://www.eortc.org/early-career/
January 23, 2026 at 8:31 AM
🎓Tomorrow is International Day of Education, a moment to celebrate the EORTC Early Career Investigator (ECI) programme, which empowers young doctors to drive #CancerResearch forward.
Meet Ioannis, Jens & Antonella from our ECI community.
Join us: https://www.eortc.org/early-career/
Meet Ioannis, Jens & Antonella from our ECI community.
Join us: https://www.eortc.org/early-career/
Reposted by European Organisation for Research and Treatment of Cancer
📣 Registration is now open for the @eortc.org #QualityofLife Group (QLG) spring meeting 2026.
📅 16-17 April
📍 Berlin, Germany
🔗 Registration link sent to all EORTC QLG members by email today ✉️
🔎 More info on venue, programme, etc, available here: www.eortc.org/event/eortc-...
#QLGmeeting
📅 16-17 April
📍 Berlin, Germany
🔗 Registration link sent to all EORTC QLG members by email today ✉️
🔎 More info on venue, programme, etc, available here: www.eortc.org/event/eortc-...
#QLGmeeting
January 21, 2026 at 10:31 AM
📣 Registration is now open for the @eortc.org #QualityofLife Group (QLG) spring meeting 2026.
📅 16-17 April
📍 Berlin, Germany
🔗 Registration link sent to all EORTC QLG members by email today ✉️
🔎 More info on venue, programme, etc, available here: www.eortc.org/event/eortc-...
#QLGmeeting
📅 16-17 April
📍 Berlin, Germany
🔗 Registration link sent to all EORTC QLG members by email today ✉️
🔎 More info on venue, programme, etc, available here: www.eortc.org/event/eortc-...
#QLGmeeting
Advancing cancer research often starts with this question: how can we improve cancer treatment for everyone?
Ahead of #WorldCancerDay, we’ll share insights from clinical research & stories from patients whose lives have been changed by clinical trials.
Stay tuned.
#EORTCimpact
Ahead of #WorldCancerDay, we’ll share insights from clinical research & stories from patients whose lives have been changed by clinical trials.
Stay tuned.
#EORTCimpact
January 21, 2026 at 11:27 AM
Advancing cancer research often starts with this question: how can we improve cancer treatment for everyone?
Ahead of #WorldCancerDay, we’ll share insights from clinical research & stories from patients whose lives have been changed by clinical trials.
Stay tuned.
#EORTCimpact
Ahead of #WorldCancerDay, we’ll share insights from clinical research & stories from patients whose lives have been changed by clinical trials.
Stay tuned.
#EORTCimpact
📢 EORTC & ema.europa.eu, together with key multiple international stakeholders, release a new CMF roadmap setting a clear direction for advancing treatment optimisation across Europe. A meaningful step toward more effective and sustainable cancer care.
Read more here: www.eortc.org/blog/2026/01...
Read more here: www.eortc.org/blog/2026/01...
January 16, 2026 at 12:37 PM
📢 EORTC & ema.europa.eu, together with key multiple international stakeholders, release a new CMF roadmap setting a clear direction for advancing treatment optimisation across Europe. A meaningful step toward more effective and sustainable cancer care.
Read more here: www.eortc.org/blog/2026/01...
Read more here: www.eortc.org/blog/2026/01...
📢 Join our team! EORTC is recruiting a Clinical Data Manager at its HQ in Brussels.
Do you hold a bachelor’s or master’s degree in a health or life sciences field and want to contribute to high-quality cancer research?👉
Apply now: https://ow.ly/Xa4x50XXipJ
Do you hold a bachelor’s or master’s degree in a health or life sciences field and want to contribute to high-quality cancer research?👉
Apply now: https://ow.ly/Xa4x50XXipJ
January 15, 2026 at 3:42 PM
📢 Join our team! EORTC is recruiting a Clinical Data Manager at its HQ in Brussels.
Do you hold a bachelor’s or master’s degree in a health or life sciences field and want to contribute to high-quality cancer research?👉
Apply now: https://ow.ly/Xa4x50XXipJ
Do you hold a bachelor’s or master’s degree in a health or life sciences field and want to contribute to high-quality cancer research?👉
Apply now: https://ow.ly/Xa4x50XXipJ
Reposted by European Organisation for Research and Treatment of Cancer
📄Findings of a new @eortc.org #QualityofLife publication in Critical Reviews in Oncology/Hematology highlight the need for improved reporting & greater prioritisation of PRO completion regardless of trial design.
🔗 doi.org/10.1016/j.cr...
#GivingVoice2Patients #CancerResearch
@msztankay.bsky.social
🔗 doi.org/10.1016/j.cr...
#GivingVoice2Patients #CancerResearch
@msztankay.bsky.social
January 15, 2026 at 1:31 PM
📄Findings of a new @eortc.org #QualityofLife publication in Critical Reviews in Oncology/Hematology highlight the need for improved reporting & greater prioritisation of PRO completion regardless of trial design.
🔗 doi.org/10.1016/j.cr...
#GivingVoice2Patients #CancerResearch
@msztankay.bsky.social
🔗 doi.org/10.1016/j.cr...
#GivingVoice2Patients #CancerResearch
@msztankay.bsky.social
📢 Don’t miss the opportunity to take part in this once-in-a-lifetime workshop.
💬 Feedback from 2025 participants of the #MCCRWorkshop
📅 13–18 June 2026
🚨Deadline: 30 January 2026
👉 Apply now: https://event.eortc.org/mccr2026/application-submission/
#clinicaltrials #clinicaltrialdesign
💬 Feedback from 2025 participants of the #MCCRWorkshop
📅 13–18 June 2026
🚨Deadline: 30 January 2026
👉 Apply now: https://event.eortc.org/mccr2026/application-submission/
#clinicaltrials #clinicaltrialdesign
January 15, 2026 at 12:01 PM
📢 Don’t miss the opportunity to take part in this once-in-a-lifetime workshop.
💬 Feedback from 2025 participants of the #MCCRWorkshop
📅 13–18 June 2026
🚨Deadline: 30 January 2026
👉 Apply now: https://event.eortc.org/mccr2026/application-submission/
#clinicaltrials #clinicaltrialdesign
💬 Feedback from 2025 participants of the #MCCRWorkshop
📅 13–18 June 2026
🚨Deadline: 30 January 2026
👉 Apply now: https://event.eortc.org/mccr2026/application-submission/
#clinicaltrials #clinicaltrialdesign
The final analysis of the CATNON trial is now published in The Lancet Oncology.
This landmark study helps define a new standard of care for patients with 1p/19q non-codeleted anaplastic glioma, building on results presented at #EANO2025.
🔗 https://ow.ly/WpKF50XWa0G
#EORTC #CATNON #NeuroOncology
This landmark study helps define a new standard of care for patients with 1p/19q non-codeleted anaplastic glioma, building on results presented at #EANO2025.
🔗 https://ow.ly/WpKF50XWa0G
#EORTC #CATNON #NeuroOncology
January 13, 2026 at 3:30 PM
The final analysis of the CATNON trial is now published in The Lancet Oncology.
This landmark study helps define a new standard of care for patients with 1p/19q non-codeleted anaplastic glioma, building on results presented at #EANO2025.
🔗 https://ow.ly/WpKF50XWa0G
#EORTC #CATNON #NeuroOncology
This landmark study helps define a new standard of care for patients with 1p/19q non-codeleted anaplastic glioma, building on results presented at #EANO2025.
🔗 https://ow.ly/WpKF50XWa0G
#EORTC #CATNON #NeuroOncology
👏 Earlier today, Ana Joaquim took part in the EHNS workshop on Perioperative Immunotherapy for Head and Neck Cancer in Lausanne.
She joined the expert panel “Adjuvant, neo‑adjuvant or both?” this morning, contributing to discussions on optimising perioperative strategies for patients. 🔬
She joined the expert panel “Adjuvant, neo‑adjuvant or both?” this morning, contributing to discussions on optimising perioperative strategies for patients. 🔬
January 9, 2026 at 3:42 PM
👏 Earlier today, Ana Joaquim took part in the EHNS workshop on Perioperative Immunotherapy for Head and Neck Cancer in Lausanne.
She joined the expert panel “Adjuvant, neo‑adjuvant or both?” this morning, contributing to discussions on optimising perioperative strategies for patients. 🔬
She joined the expert panel “Adjuvant, neo‑adjuvant or both?” this morning, contributing to discussions on optimising perioperative strategies for patients. 🔬
📄 New in @jamanetworkopen.com
Researchers led by Sam Sodergren have developed a new EORTC #QoL questionnaire for adolescents & young adults with cancer – capturing challenges &positive adaptations unique to this age group.
👉 www.eortc.org/blog/2026/01...
@sotonhsciences.bsky.social @qol.eortc.org
Researchers led by Sam Sodergren have developed a new EORTC #QoL questionnaire for adolescents & young adults with cancer – capturing challenges &positive adaptations unique to this age group.
👉 www.eortc.org/blog/2026/01...
@sotonhsciences.bsky.social @qol.eortc.org
January 8, 2026 at 1:20 PM
📄 New in @jamanetworkopen.com
Researchers led by Sam Sodergren have developed a new EORTC #QoL questionnaire for adolescents & young adults with cancer – capturing challenges &positive adaptations unique to this age group.
👉 www.eortc.org/blog/2026/01...
@sotonhsciences.bsky.social @qol.eortc.org
Researchers led by Sam Sodergren have developed a new EORTC #QoL questionnaire for adolescents & young adults with cancer – capturing challenges &positive adaptations unique to this age group.
👉 www.eortc.org/blog/2026/01...
@sotonhsciences.bsky.social @qol.eortc.org
Reposted by European Organisation for Research and Treatment of Cancer
📘 Just published:
M Petersen et al. evaluated the use of cross-domain prediction to tailor start item selection in the @eortc.org CAT Core. Results suggest improved measurement precision for short computer-adaptive tests (CATs).
👉 doi.org/10.1007/s111...
#QualityofLife @mogensgroenvold.bsky.social
M Petersen et al. evaluated the use of cross-domain prediction to tailor start item selection in the @eortc.org CAT Core. Results suggest improved measurement precision for short computer-adaptive tests (CATs).
👉 doi.org/10.1007/s111...
#QualityofLife @mogensgroenvold.bsky.social
January 6, 2026 at 2:59 PM
📘 Just published:
M Petersen et al. evaluated the use of cross-domain prediction to tailor start item selection in the @eortc.org CAT Core. Results suggest improved measurement precision for short computer-adaptive tests (CATs).
👉 doi.org/10.1007/s111...
#QualityofLife @mogensgroenvold.bsky.social
M Petersen et al. evaluated the use of cross-domain prediction to tailor start item selection in the @eortc.org CAT Core. Results suggest improved measurement precision for short computer-adaptive tests (CATs).
👉 doi.org/10.1007/s111...
#QualityofLife @mogensgroenvold.bsky.social
📢 Don’t miss the EORTC webinar Patient Preferences Matter, happening this Friday, 9 January 2026.
🔗 For more information: www.eortc.org/event/joint-...
#PatientPreferences #CancerResearch #EORTC #ClinicalTrials
🔗 For more information: www.eortc.org/event/joint-...
#PatientPreferences #CancerResearch #EORTC #ClinicalTrials
How much do patient preferences shape cancer research?
Join our webinar with OAC & @qol.eortc.org to explore why listening to patients, especially older adults, matters.
🗓 Jan 9, 2026 | 17:00–18:30 CET
🔗 Registration soon: www.eortc.org/event/joint-...
#CancerCare #OlderAdults
Join our webinar with OAC & @qol.eortc.org to explore why listening to patients, especially older adults, matters.
🗓 Jan 9, 2026 | 17:00–18:30 CET
🔗 Registration soon: www.eortc.org/event/joint-...
#CancerCare #OlderAdults
January 7, 2026 at 3:42 PM
📢 Don’t miss the EORTC webinar Patient Preferences Matter, happening this Friday, 9 January 2026.
🔗 For more information: www.eortc.org/event/joint-...
#PatientPreferences #CancerResearch #EORTC #ClinicalTrials
🔗 For more information: www.eortc.org/event/joint-...
#PatientPreferences #CancerResearch #EORTC #ClinicalTrials
We were honoured to welcome Princess Laetitia of Belgium to EORTC HQ last week! Ahead of her Edinburgh Marathon 2026 run for cancer research, she met our CEO Denis Lacombe, MD and learned about EORTC’s mission to advance cancer treatments.
Grateful for her commitment!
#Oncology
Grateful for her commitment!
#Oncology
December 23, 2025 at 11:33 AM
We were honoured to welcome Princess Laetitia of Belgium to EORTC HQ last week! Ahead of her Edinburgh Marathon 2026 run for cancer research, she met our CEO Denis Lacombe, MD and learned about EORTC’s mission to advance cancer treatments.
Grateful for her commitment!
#Oncology
Grateful for her commitment!
#Oncology
📢 Our December EORTC Newsletter is out!
Featuring key milestones, research highlights, and upcoming initiatives.
👉 Read the latest edition: us2.campaign-archive.com.
#CancerResearch #EORTC #Oncology
Featuring key milestones, research highlights, and upcoming initiatives.
👉 Read the latest edition: us2.campaign-archive.com.
#CancerResearch #EORTC #Oncology
December 19, 2025 at 3:30 PM
📢 Our December EORTC Newsletter is out!
Featuring key milestones, research highlights, and upcoming initiatives.
👉 Read the latest edition: us2.campaign-archive.com.
#CancerResearch #EORTC #Oncology
Featuring key milestones, research highlights, and upcoming initiatives.
👉 Read the latest edition: us2.campaign-archive.com.
#CancerResearch #EORTC #Oncology
📢There’s still time to make a difference!
Your donation helps EORTC advance research that transforms cancer care across Europe and beyond.
Together, we can ensure equitable access to innovative treatments.
🔗Link to donate: donate.eortcresearchfund.org/eoy/~my-dona...
#LeavingNoCancerPatientBehind
Your donation helps EORTC advance research that transforms cancer care across Europe and beyond.
Together, we can ensure equitable access to innovative treatments.
🔗Link to donate: donate.eortcresearchfund.org/eoy/~my-dona...
#LeavingNoCancerPatientBehind
December 17, 2025 at 4:00 PM
📢There’s still time to make a difference!
Your donation helps EORTC advance research that transforms cancer care across Europe and beyond.
Together, we can ensure equitable access to innovative treatments.
🔗Link to donate: donate.eortcresearchfund.org/eoy/~my-dona...
#LeavingNoCancerPatientBehind
Your donation helps EORTC advance research that transforms cancer care across Europe and beyond.
Together, we can ensure equitable access to innovative treatments.
🔗Link to donate: donate.eortcresearchfund.org/eoy/~my-dona...
#LeavingNoCancerPatientBehind
📢 Registration is now open!
Join us on 9 January 2026 for the EORTC webinar Patient Preferences Matter.
🔗 Register here: www.eortc.org/event/joint-...
#PatientPreferences #CancerResearch #EORTC #ClinicalTrials
Join us on 9 January 2026 for the EORTC webinar Patient Preferences Matter.
🔗 Register here: www.eortc.org/event/joint-...
#PatientPreferences #CancerResearch #EORTC #ClinicalTrials
December 12, 2025 at 1:25 PM
📢 Registration is now open!
Join us on 9 January 2026 for the EORTC webinar Patient Preferences Matter.
🔗 Register here: www.eortc.org/event/joint-...
#PatientPreferences #CancerResearch #EORTC #ClinicalTrials
Join us on 9 January 2026 for the EORTC webinar Patient Preferences Matter.
🔗 Register here: www.eortc.org/event/joint-...
#PatientPreferences #CancerResearch #EORTC #ClinicalTrials
🙏 A big thank you to everyone supporting our mission!
Your engagement drives progress in cancer research and patient care. Let’s keep going!
🔗 Stand with us to drive research impact: donate.eortcresearchfund.org/eoy/~my-dona...
#ThankYou #CancerResearch #LeavingNoCancerPatientBehind
Your engagement drives progress in cancer research and patient care. Let’s keep going!
🔗 Stand with us to drive research impact: donate.eortcresearchfund.org/eoy/~my-dona...
#ThankYou #CancerResearch #LeavingNoCancerPatientBehind
December 11, 2025 at 12:13 PM
🙏 A big thank you to everyone supporting our mission!
Your engagement drives progress in cancer research and patient care. Let’s keep going!
🔗 Stand with us to drive research impact: donate.eortcresearchfund.org/eoy/~my-dona...
#ThankYou #CancerResearch #LeavingNoCancerPatientBehind
Your engagement drives progress in cancer research and patient care. Let’s keep going!
🔗 Stand with us to drive research impact: donate.eortcresearchfund.org/eoy/~my-dona...
#ThankYou #CancerResearch #LeavingNoCancerPatientBehind
📢 New EORTC publication!
Systemic chemo for CRCLM:
➡️ Better PFS & OS than surgery alone
➡️ Strongest benefit in synchronous cases
🔗 Full article: www.eortc.org/publications/
#CancerResearch #EORTC #Oncology
Systemic chemo for CRCLM:
➡️ Better PFS & OS than surgery alone
➡️ Strongest benefit in synchronous cases
🔗 Full article: www.eortc.org/publications/
#CancerResearch #EORTC #Oncology
December 11, 2025 at 10:59 AM
📢 New EORTC publication!
Systemic chemo for CRCLM:
➡️ Better PFS & OS than surgery alone
➡️ Strongest benefit in synchronous cases
🔗 Full article: www.eortc.org/publications/
#CancerResearch #EORTC #Oncology
Systemic chemo for CRCLM:
➡️ Better PFS & OS than surgery alone
➡️ Strongest benefit in synchronous cases
🔗 Full article: www.eortc.org/publications/
#CancerResearch #EORTC #Oncology
Join our team! 🚀
EORTC is hiring a Junior Pharmacovigilance Manager in Brussels!
🎯 You have a Life Sciences degree + 0–2 yrs in SAE/clinical safety/pharmacovigilance? Contribute to cancer research and patient safety.
👉 Apply now! ow.ly/sAMh50XGjwO
#Jobs #Pharmacovigilance
EORTC is hiring a Junior Pharmacovigilance Manager in Brussels!
🎯 You have a Life Sciences degree + 0–2 yrs in SAE/clinical safety/pharmacovigilance? Contribute to cancer research and patient safety.
👉 Apply now! ow.ly/sAMh50XGjwO
#Jobs #Pharmacovigilance
December 9, 2025 at 3:23 PM
Join our team! 🚀
EORTC is hiring a Junior Pharmacovigilance Manager in Brussels!
🎯 You have a Life Sciences degree + 0–2 yrs in SAE/clinical safety/pharmacovigilance? Contribute to cancer research and patient safety.
👉 Apply now! ow.ly/sAMh50XGjwO
#Jobs #Pharmacovigilance
EORTC is hiring a Junior Pharmacovigilance Manager in Brussels!
🎯 You have a Life Sciences degree + 0–2 yrs in SAE/clinical safety/pharmacovigilance? Contribute to cancer research and patient safety.
👉 Apply now! ow.ly/sAMh50XGjwO
#Jobs #Pharmacovigilance
📢 We’re hiring a Clinical Operations Assistant (COA)!
Support our Clinical Ops teams and join an international non-profit organisation improving survival and quality of life for cancer patients.
Apply now 👉 www.eortc.org/job/clinical...
#WorkWithUs #CancerResearch #Vacancy
Support our Clinical Ops teams and join an international non-profit organisation improving survival and quality of life for cancer patients.
Apply now 👉 www.eortc.org/job/clinical...
#WorkWithUs #CancerResearch #Vacancy
December 9, 2025 at 1:24 PM
📢 We’re hiring a Clinical Operations Assistant (COA)!
Support our Clinical Ops teams and join an international non-profit organisation improving survival and quality of life for cancer patients.
Apply now 👉 www.eortc.org/job/clinical...
#WorkWithUs #CancerResearch #Vacancy
Support our Clinical Ops teams and join an international non-profit organisation improving survival and quality of life for cancer patients.
Apply now 👉 www.eortc.org/job/clinical...
#WorkWithUs #CancerResearch #Vacancy
🚀 EORTC at #ASH25!
We’re joining the global hematology community in Orlando!
Our poster presentations feature:
➡️ Long-term follow-up from EORTC 1301
➡️ Insights from AML1301 to predict response to hypomethylating treatments.
#EORTCResearch #PatientOutcomes @ash.hematology.org
We’re joining the global hematology community in Orlando!
Our poster presentations feature:
➡️ Long-term follow-up from EORTC 1301
➡️ Insights from AML1301 to predict response to hypomethylating treatments.
#EORTCResearch #PatientOutcomes @ash.hematology.org
December 5, 2025 at 10:40 AM
🚀 EORTC at #ASH25!
We’re joining the global hematology community in Orlando!
Our poster presentations feature:
➡️ Long-term follow-up from EORTC 1301
➡️ Insights from AML1301 to predict response to hypomethylating treatments.
#EORTCResearch #PatientOutcomes @ash.hematology.org
We’re joining the global hematology community in Orlando!
Our poster presentations feature:
➡️ Long-term follow-up from EORTC 1301
➡️ Insights from AML1301 to predict response to hypomethylating treatments.
#EORTCResearch #PatientOutcomes @ash.hematology.org
Older adults are most affected by cancer, yet often excluded from trials. Young patients face unique challenges too.
At #EORTC, we’re committed to #InclusiveTrials for ALL ages.
On #WCD, we renewed our promise: #LeavingNoCancerPatientBehind.
👉Donate here: donate.eortcresearchfund.org/eoy/~my-dona...
At #EORTC, we’re committed to #InclusiveTrials for ALL ages.
On #WCD, we renewed our promise: #LeavingNoCancerPatientBehind.
👉Donate here: donate.eortcresearchfund.org/eoy/~my-dona...
December 4, 2025 at 1:49 PM
Older adults are most affected by cancer, yet often excluded from trials. Young patients face unique challenges too.
At #EORTC, we’re committed to #InclusiveTrials for ALL ages.
On #WCD, we renewed our promise: #LeavingNoCancerPatientBehind.
👉Donate here: donate.eortcresearchfund.org/eoy/~my-dona...
At #EORTC, we’re committed to #InclusiveTrials for ALL ages.
On #WCD, we renewed our promise: #LeavingNoCancerPatientBehind.
👉Donate here: donate.eortcresearchfund.org/eoy/~my-dona...
Reposted by European Organisation for Research and Treatment of Cancer
🚨 Publication alert!
A new international study validates the @eortc.org #QualityofLife PATSAT-C33 & OUT-PATSAT7 questionnaires as robust tools for measuring patient satisfaction in cancer care. 🌟
📰 Access the paper: doi.org/10.1186/s128...
#GivingVoice2Patients #CancerResearch
@miekevhr.bsky.social
A new international study validates the @eortc.org #QualityofLife PATSAT-C33 & OUT-PATSAT7 questionnaires as robust tools for measuring patient satisfaction in cancer care. 🌟
📰 Access the paper: doi.org/10.1186/s128...
#GivingVoice2Patients #CancerResearch
@miekevhr.bsky.social
December 3, 2025 at 9:06 AM
🚨 Publication alert!
A new international study validates the @eortc.org #QualityofLife PATSAT-C33 & OUT-PATSAT7 questionnaires as robust tools for measuring patient satisfaction in cancer care. 🌟
📰 Access the paper: doi.org/10.1186/s128...
#GivingVoice2Patients #CancerResearch
@miekevhr.bsky.social
A new international study validates the @eortc.org #QualityofLife PATSAT-C33 & OUT-PATSAT7 questionnaires as robust tools for measuring patient satisfaction in cancer care. 🌟
📰 Access the paper: doi.org/10.1186/s128...
#GivingVoice2Patients #CancerResearch
@miekevhr.bsky.social
📢 EORTC is recruiting a Medical Doctor Fellow! Join the RECIST Working Group to help shape the future of tumour-response assessment in clinical trials, from immunotherapy to AI-driven imaging. Based in Brussels.
Apply now: www.eortc.org/job/medical-...
#RECIST #Oncology #ClinicalTrials
Apply now: www.eortc.org/job/medical-...
#RECIST #Oncology #ClinicalTrials
December 3, 2025 at 10:22 AM
📢 EORTC is recruiting a Medical Doctor Fellow! Join the RECIST Working Group to help shape the future of tumour-response assessment in clinical trials, from immunotherapy to AI-driven imaging. Based in Brussels.
Apply now: www.eortc.org/job/medical-...
#RECIST #Oncology #ClinicalTrials
Apply now: www.eortc.org/job/medical-...
#RECIST #Oncology #ClinicalTrials